Anthony Valenzuela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anthony Valenzuela has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Pamela J. Lein
University of California, Davis
4 shared publications - Hans-Joachim Lehmler
Department of Occupational and Environmental Health, University of Iowa, Iowa City, Iowa, USA
3 shared publications Anchaleena James
Department of Biomedical Engineering, University of California, Davis, United States
2 shared publications- Crystal M. Roach
Department of Occupational and Environmental Health, College of Public Health, The University of Iowa, Iowa City, IA 52242, USA
2 shared publications - Keith J. Bein
University of California, Davis
2 shared publications - Nathifa Nasim
Department of Molecular Biosciences, University of California, Davis, United States
2 shared publications
Latest Publications
- Open Access
- 4 October 2026
- Published by Elsevier in NeuroToxicology
- Vol. 117
Cytochrome P450 expression influences behavioral responses to 3,3′-dichlorobiphenyl (PCB 11) in juvenile male and female mice exposed throughout gestation and lactation
- 4 October 2026
- Published by Elsevier in NeuroToxicology
- Vol. 117
Open AccessCytochrome P450 expression influences behavioral responses to 3,3′-dichlorobiphenyl (PCB 11) in juvenile male and female mice exposed throughout gestation and lactation
- Open Access
- 27 January 2026
- Published by Elsevier in Environmental Pollution
- Vol. 393, 127730
Spatial and spectral mapping of traffic-related nanoparticles in hippocampal subregions of an Alzheimer disease model
- 27 January 2026
- Published by Elsevier in Environmental Pollution
- Vol. 393, 127730
Open AccessSpatial and spectral mapping of traffic-related nanoparticles in hippocampal subregions of an Alzheimer disease model
- Open Access
- 8 December 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 100 (3) , 943-957
3,3'-Dichlorobiphenyl (PCB 11) alters the hepatic expression of cytochrome P450 enzymes in the liver of mouse dams exposed orally during pregnancy and lactation
Healthy maternal metabolism is critical during pregnancy and lactation to support fetal development and protect against environmental toxins. Polychlorinated biphenyl 11 (PCB 11), a lower-chlorinated, non-legacy congener, is detected in human serum, including pregnant women and children; however, its impact during these sensitive life stages remains poorly understood. This study presents the first comprehensive hepatic proteome analysis of mouse dams exposed to PCB 11 during pregnancy and lactation. Female C57BL/6 J mice received daily oral doses of PCB 11 (0, 1.0 or 6.0 mg/kg) prior to conception through lactation. At postpartum day 21, brain, liver, and serum samples were analyzed for PCB 11 and its metabolites, and hepatic proteomic changes were assessed. Low detection of PCB 11 and its metabolites was observed in tissues, suggesting rapid clearance. Metabolite screening revealed OH-PCB 11, PCB 11 sulfate, and OH-PCB 11 sulfate metabolites in serum. Global proteomics identified significant alterations in hepatic protein expression, including downregulation of cytochrome P450 enzymes, solute carriers, and enzymes involved in fatty acid and steroid metabolism. Pathway enrichment analyses indicated disruptions in xenobiotic metabolism and endocrine pathways. These findings suggest that PCB 11 exposure during pregnancy and lactation impairs hepatic detoxification and metabolic capacity, potentially compromising maternal and offspring health. This work highlights the need for further investigation into the long-term consequences of PCB 11 exposure during pregnancy and lactation.
- 8 December 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 100 (3) , 943-957
Open Access3,3'-Dichlorobiphenyl (PCB 11) alters the hepatic expression of cytochrome P450 enzymes in the liver of mouse dams exposed orally during pregnancy and lactation
Healthy maternal metabolism is critical during pregnancy and lactation to support fetal development and protect against environmental toxins. Polychlorinated biphenyl 11 (PCB 11), a lower-chlorinated, non-legacy congener, is detected in human serum, including pregnant women and children; however, its impact during these sensitive life stages remains poorly understood. This study presents the first comprehensive hepatic proteome analysis of mouse dams exposed to PCB 11 during pregnancy and lactation. Female C57BL/6 J mice received daily oral doses of PCB 11 (0, 1.0 or 6.0 mg/kg) prior to conception through lactation. At postpartum day 21, brain, liver, and serum samples were analyzed for PCB 11 and its metabolites, and hepatic proteomic changes were assessed. Low detection of PCB 11 and its metabolites was observed in tissues, suggesting rapid clearance. Metabolite screening revealed OH-PCB 11, PCB 11 sulfate, and OH-PCB 11 sulfate metabolites in serum. Global proteomics identified significant alterations in hepatic protein expression, including downregulation of cytochrome P450 enzymes, solute carriers, and enzymes involved in fatty acid and steroid metabolism. Pathway enrichment analyses indicated disruptions in xenobiotic metabolism and endocrine pathways. These findings suggest that PCB 11 exposure during pregnancy and lactation impairs hepatic detoxification and metabolic capacity, potentially compromising maternal and offspring health. This work highlights the need for further investigation into the long-term consequences of PCB 11 exposure during pregnancy and lactation.
- Open Access
Spatial and spectral mapping of traffic-related air pollution (TRAP) nanoparticles in relation to plaques and inflammatory markers in an Alzheimer disease model
Chronic exposure to traffic-related air pollution (TRAP) is linked to increased risk of neurodegenerative diseases, including Alzheimer disease (AD). Ultrafine particulate matter (UFPM) is a suspected driver of TRAP neurotoxicity, but its spatial interactions with AD pathology remain poorly defined. We investigated the distribution, composition, and pathological context of TRAP-derived UFPM in the hippocampus of TgF344-AD rats chronically exposed to TRAP or filtered air (FA) for 14 months. Using a multimodal imaging workflow that combines enhanced darkfield hyperspectral imaging (EDF-HSI) with confocal immunofluorescence for microglia (CD68/Iba1) and amyloid beta (Aβ) plaques (Thioflavin S), we mapped the localization and spectral properties of UFPM in situ. UFPM accumulation was elevated in TRAP-exposed females, suggesting sex-specific vulnerability in blood-brain barrier (BBB) permeability or particle retention. Particles near plaques showed red-shifted spectral signatures, consistent with biochemical transformation. Dimension reduction revealed clustering of particle spectra by TRAP exposure and plaque proximity. However, UFPM was rarely found within plaques or microglia, implying indirect neuroimmune modulation. These findings highlight a novel spatial and spectral imaging approach for characterizing environmental nanoparticle interactions in the brain and suggest that chronic TRAP exposure may influence AD-related inflammation and pathology in a sex-and region-dependent manner. Synopsis This study shows that chronic traffic-related air pollution alters ultrafine particulate matter deposition and neuroinflammation in a rodent Alzheimer model, revealing region- and sex-specific vulnerability in the brain’s response to environmental exposure.
Open AccessSpatial and spectral mapping of traffic-related air pollution (TRAP) nanoparticles in relation to plaques and inflammatory markers in an Alzheimer disease model
Chronic exposure to traffic-related air pollution (TRAP) is linked to increased risk of neurodegenerative diseases, including Alzheimer disease (AD). Ultrafine particulate matter (UFPM) is a suspected driver of TRAP neurotoxicity, but its spatial interactions with AD pathology remain poorly defined. We investigated the distribution, composition, and pathological context of TRAP-derived UFPM in the hippocampus of TgF344-AD rats chronically exposed to TRAP or filtered air (FA) for 14 months. Using a multimodal imaging workflow that combines enhanced darkfield hyperspectral imaging (EDF-HSI) with confocal immunofluorescence for microglia (CD68/Iba1) and amyloid beta (Aβ) plaques (Thioflavin S), we mapped the localization and spectral properties of UFPM in situ. UFPM accumulation was elevated in TRAP-exposed females, suggesting sex-specific vulnerability in blood-brain barrier (BBB) permeability or particle retention. Particles near plaques showed red-shifted spectral signatures, consistent with biochemical transformation. Dimension reduction revealed clustering of particle spectra by TRAP exposure and plaque proximity. However, UFPM was rarely found within plaques or microglia, implying indirect neuroimmune modulation. These findings highlight a novel spatial and spectral imaging approach for characterizing environmental nanoparticle interactions in the brain and suggest that chronic TRAP exposure may influence AD-related inflammation and pathology in a sex-and region-dependent manner. Synopsis This study shows that chronic traffic-related air pollution alters ultrafine particulate matter deposition and neuroinflammation in a rodent Alzheimer model, revealing region- and sex-specific vulnerability in the brain’s response to environmental exposure.
- Open Access
- 25 June 2018
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2018, 1-10
In VivoMRI of Functionalized Iron Oxide Nanoparticles for Brain Inflammation
Microglia are intrinsic components of the brain immune system and are activated in many central nervous system disorders. The ability to noninvasively image these cells would provide valuable information for both research and clinical applications. Today, most imaging probes for activated microglia are mainly designed for positron emission tomography (PET) and target translocator proteins that also reside on other cerebral cells. The PET images obtained are not specific for microglia-driven inflammation. Here, we describe a potential PET/MRI multimodal imaging probe that selectively targets the scavenger receptor class A (SR-A) expressed on activated microglia. These sulfated dextran-coated iron oxide (SDIO) nanoparticles are avidly taken up by microglia and appear to be nontoxic when administered intravenously in a mouse model. Intravenous administration of this SDIO demonstrated visualization by-weighted MRI of microglia activated by intracerebral administration of tumor necrosis factor alpha (TNF-α). The contrast was significantly enhanced by SDIO, whereas there was little to no contrast change in animals treated with nontargeted nanoparticles or untreated controls. Thus, SR-A targeting represents a promising strategy to image activated microglia in the brain.- 25 June 2018
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 2018, 1-10
Open AccessIn VivoMRI of Functionalized Iron Oxide Nanoparticles for Brain Inflammation
Microglia are intrinsic components of the brain immune system and are activated in many central nervous system disorders. The ability to noninvasively image these cells would provide valuable information for both research and clinical applications. Today, most imaging probes for activated microglia are mainly designed for positron emission tomography (PET) and target translocator proteins that also reside on other cerebral cells. The PET images obtained are not specific for microglia-driven inflammation. Here, we describe a potential PET/MRI multimodal imaging probe that selectively targets the scavenger receptor class A (SR-A) expressed on activated microglia. These sulfated dextran-coated iron oxide (SDIO) nanoparticles are avidly taken up by microglia and appear to be nontoxic when administered intravenously in a mouse model. Intravenous administration of this SDIO demonstrated visualization by-weighted MRI of microglia activated by intracerebral administration of tumor necrosis factor alpha (TNF-α). The contrast was significantly enhanced by SDIO, whereas there was little to no contrast change in animals treated with nontargeted nanoparticles or untreated controls. Thus, SR-A targeting represents a promising strategy to image activated microglia in the brain.